<i>IDH2</i>-mutated acute myeloid leukemia in older adults: prognostic signal is not regimen selection. Comment on: "<i>IDH2</i> mutation is associated with favorable outcome among older adults with newly diagnosed acute myeloid leukemia treated with hypomethylating agent-based therapy"

Yanlu Wang; Jiahui Lu

doi:10.3324/haematol.2026.301220

Comments

IDH2-mutated acute myeloid leukemia in older adults: prognostic signal is not regimen selection. Comment on: "IDH2 mutation is associated with favorable outcome among older adults with newly diagnosed acute myeloid leukemia treated with hypomethylating agent-based therapy"

Yanlu Wang
Jiahui Lu

Clinical Hematology Center and Institute of Hematology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai

Haematologica Early view May 21, 2026 https://doi.org/10.3324/haematol.2026.301220

Abstract

Not available.

Figures & Tables

Article Information

Early view : Comments

DOI

https://doi.org/10.3324/haematol.2026.301220

Published

2026-05-21

Published By

Ferrata Storti Foundation, Pavia, Italy

Print ISSN

0390-6078

Online ISSN

1592-8721

Copyright & Usage

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

Online Views

61

PDF Downloads

46

No Data

PlumX

IDH2-mutated acute myeloid leukemia in older adults: prognostic signal is not regimen selection. Comment on: "IDH2 mutation is associated with favorable outcome among older adults with newly diagnosed acute myeloid leukemia treated with hypomethylating agent-based therapy"

Abstract

Figures & Tables

Article Information

Article Usage

Download Citation

Navigate

For Authors

For Reviewers

For Advertisers

Education

Privacy

More